Latest filing published 04 Oct 2022 for Alector, Inc..
Filing timeline
BuySaleInsider track record
Robert King: trading record in brief
Filings by Robert King span 2 companies, the busiest being Alector, Inc. and Sciclone Pharmaceuticals Inc. We count 24 filings; the first trade dates from 12 August 2016 and the latest from 1 October 2022.
The open-market record consists of 16 sales worth €3.3M, with no purchase. Outside the open market, there are 4 share grants and 4 option exercises. Since January 2022: no purchases and 3 sales on the market.
The latest filing, published on 4 October 2022, reports a share grant in Alector, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert King
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,576 shares0Common StockSEC:0001209191-22-052564:0
- 176 shares@ US$10.62050.9% of flowCommon StockSEC:0001209191-22-049000:0
- 177 shares@ US$8.70950.7% of flowCommon StockSEC:0001209191-22-034559:0
- 287 shares@ US$15.56791.8% of flowCommon StockSEC:0001209191-22-015742:0
- 250 shares@ US$20.092.0% of flowCommon StockSEC:0001209191-21-067885:0
- 5,939 shares0Common StockSEC:0001209191-21-060030:0
- 7,967 shares0Common StockSEC:0001209191-21-059148:0
- 30,000 shares@ US$10.147.7% of flowCommon StockSEC:0001209191-21-045916:1
- 60,000 shares@ US$31.1447.2% of flowCommon StockSEC:0001209191-21-045916:2
- 30,000 shares@ US$8.1694.6% of flowCommon StockSEC:0001209191-21-045916:0
- 45,000 shares0Common StockSEC:0001209191-21-031843:0
- 3,365 shares@ US$26.245.8% of flowCommon StockSEC:0001209191-20-030601:0
- 8,632 shares@ US$27.0215.3% of flowCommon StockSEC:0001209191-20-030601:1
- 3,003 shares@ US$27.785.5% of flowCommon StockSEC:0001209191-20-030601:2
- 4,668 shares@ US$29.098.3% of flowCommon StockSEC:0001209191-20-010241:0
- 10,332 shares@ US$29.7718.8% of flowCommon StockSEC:0001209191-20-010241:1
- 14,997 shares@ US$22.0119.7% of flowCommon StockSEC:0001209191-20-004706:0
- 3 shares@ US$22.010.0% of flowCommon StockSEC:0001209191-20-004706:1
- 7,500 shares@ US$15.927.2% of flowCommon StockSEC:0001209191-19-057203:0
- 7,500 shares@ US$15.006.7% of flowCommon StockSEC:0001209191-19-046985:0
- 2,000 shares0Common StockSEC:0000880771-16-000175:2
- 46,667 shares@ US$4.5229.4% of flowCommon StockSEC:0000880771-16-000175:0
- 46,667 shares@ US$10.4167.7% of flowCommon StockSEC:0000880771-16-000175:1
- 2,000 shares@ US$10.412.9% of flowCommon StockSEC:0000880771-16-000175:3
24 of 24 declarations
